A phase II study of weekly docetaxel (T), estramustine (E), and celecoxib (C) in patients with hormone refractory prostate cancer (HRPC).

被引：0
|
作者：
Mellado, B
Font, A
Carles, J
Catalán, G
Larriba, JLG
Gallardo, E
Fernández, LA
Nogué, M
Lianes, P
Del Alba, AG
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Univ Barcelona, Hosp Germans Trias & Pujol, Barcelona, Spain
[3] Hosp del Mar, Barcelona, Spain
[4] Hosp Son Liatzer, Islas Baleares, Spain
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Corp Sanitaria Parc Tauli, Barcelona, Spain
[7] Hosp Terrassa, Barcelona, Spain
[8] Hosp Gen Vic, Barcelona, Spain
[9] Hosp Mataro, Barcelona, Spain
[10] Hosp Son Dureta, Islas Baleares, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：434S / 434S
页数：1
相关论文
共 50 条
  • [1] A phase I study of estramustine, weekly docetaxel and carboplatin (EDC) chemotherapy in patients with hormone refractory prostate cancer (HRPC).
    Oh, WK
    Hagmann, E
    Manola, J
    George, DJ
    Gilligan, TD
    Smith, MR
    Kaufman, DS
    Kantoff, PW
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 420S - 420S
  • [2] Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC)
    Joseph G. Kattan
    Fady S. Farhat
    Georges Y. Chahine
    Fady L. Nasr
    Walid T. Moukadem
    Fariha C. Younes
    Nadine J. Yazbeck
    Marwan G. Ghosn
    Investigational New Drugs, 2008, 26 : 75 - 79
  • [3] Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC)
    Kattan, Joseph G.
    Farhat, Fady S.
    Chahine, Georges Y.
    Nasr, Fady L.
    Moukadem, Walid T.
    Younes, Fariha C.
    Yazbeck, Nadine J.
    Ghosn, Marwan G.
    INVESTIGATIONAL NEW DRUGS, 2008, 26 (01) : 75 - 79
  • [4] Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study
    J Carles
    A Font
    B Mellado
    M Domenech
    E Gallardo
    J L González-Larriba
    G Catalan
    J Alfaro
    A Gonzalez del Alba
    M Nogué
    P Lianes
    J M Tello
    British Journal of Cancer, 2007, 97 : 1206 - 1210
  • [5] Weekly docetaxel and estramustine in patients with hormone-refractory prostate cancer
    Copur, MS
    Ledakis, P
    Lynch, J
    Hauke, R
    Tarantolo, S
    Bolton, M
    Norvell, M
    Muhvic, J
    Hake, L
    Wendt, J
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 16 - 21
  • [6] Phase I/II study of weekly docetaxel and vinblastine in the treatment of hormone-refractory prostate cancer (HRPC).
    Ackler, JR
    Tester, WJ
    Leighton, JC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 771S - 771S
  • [7] A phase II study evaluating docetaxel (D) and one day of estramustine phosphate (EMP) in hormone refractory prostate cancer (HRPC).
    Sinibaldi, V
    Carducci, M
    Moore-Cooper, S
    Laufer, M
    Zahurak, M
    Eisenberger, M
    ANNALS OF ONCOLOGY, 2000, 11 : 77 - 77
  • [8] A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancer
    Oh, WK
    Hagmann, E
    Manola, J
    George, DJ
    Gilligan, TD
    Jacobson, JO
    Smith, MR
    Kaufman, DS
    Kantoff, PW
    CLINICAL CANCER RESEARCH, 2005, 11 (01) : 284 - 289
  • [9] Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer:: final results from a phase II study Clinical Studies
    Carles, J.
    Font, A.
    Mellado, B.
    Domenech, M.
    Gallardo, E.
    Gonzalez-Larriba, J. L.
    Catalan, G.
    Alfaro, J.
    del Alba, A. Gonzalez
    Nogue, M.
    Lianes, P.
    Tello, J. M.
    BRITISH JOURNAL OF CANCER, 2007, 97 (09) : 1206 - 1210
  • [10] Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients
    Takenaka, Atsushi
    Yamada, Yuji
    Kurahashi, Toshifumi
    Soga, Hideo
    Miyake, Hideaki
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (01) : 106 - 109
12345